Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1

Transplantation

Volumn 82, Issue 1, 2006, Pages 48-54

  Nissel, Richard ^a,k   Latta, Kay ^b   Gagnadoux, Marie France ^c   Kelly, Deirdre ^d   Hulton, Sally ^d   Kemper, Markus J ^e   Ruder, Hans ^f   Söderdahl, Gunnar ^g   Otte, Jean B ^h   Cochat, Pierre ⁱ   Roquet, Olga ⁱ   Jamieson, Neville V ^j   Haffner, Dieter ^a,k  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Clementine Kinderhospital   (Germany)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ UNIVERSITÉ LYON 1   (France)

^j ADDENBROOKE S HOSPITAL   (United Kingdom)

^k ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

more..

Author keywords

Growth; Kidney transplantation; Liver transplantation; Primary hyperoxaluria

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; OXALIC ACID DERIVATIVE;

ADOLESCENT; ARTICLE; BODY GROWTH; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; GRAFT REJECTION; GROWTH RETARDATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; OXALOSIS 1; PRIORITY JOURNAL; TREATMENT OUTCOME; CLINICAL TRIAL; GROWTH DISORDER; MULTICENTER STUDY; URINE;

BODY HEIGHT; CHILD; FEMALE; GROWTH DISORDERS; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; OXALATES;

EID: 33747473668     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000225831.35143.06     Document Type: Article

References (36)

1. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol 2001; 12: 1986.
2. Cochat P, Deloraine A, Olive F, et al. Primary hyperoxaluria type 1: the therapeutic dilemma. Adv Nephrol Necker Hosp 1995; 24: 227-242.
3. Morgan SH, Purkiss P, Watts RW, Mansell MA. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 1987; 46: 253.
4. Broyer M, Jouvet P, Niaudet P, et al. Management of oxalosis. Kidney Int Suppl 1996; 53: S93-S98.
5. O'Callaghan JW, Arbuckle SM, Craswell PW, et al. Rapid progression of oxalosis-induced cardiomyopathy despite adequate haemodialysis. Miner Electrolyte Metab 1984; 10: 48.
6. Haffner D, Weinfurth A, Manz F, et al. Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 1999; 83: 250.
7. Millan MT, Berquist WE, So SK, et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 2003; 76: 1458.
8. Hanna JD, Krieg RJ, Scheinman JI, Chan JCM. Effects of uremia on growth in children. Sem Nephrol 1996; 16: 230.
9. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001; 108: 467.
10. Marangella M, Vitale C, Petrarulo M, et al. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 1995; 48: 182.
11. Haffner D, Cochat P, Otto G, et al. When should isolated liver transplantation be performed in primary hyperoxaluria type 1? Follow-up report of two children. Nephrol Dial Transplant 1995; 10 Suppl 8: 47-52.
12. Cochat P, Gaulier JM, Koch Nogueira PC, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999; 158 Suppl 2: S75-S80.
13. Shapiro R, Weismann I, Mandel H, et al. Primary hyperoxaluria type 1: Improved outcome with timely liver transplantation: A single-center report of 36 children. Transplantation 2001; 72: 428.
14. Jamieson NV. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 Transplant Registry experience 1984-2004. Am J Nephrol 2005; 25: 282.
15. Watts RW, Calne RY, Rolles K, et al. Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987; 2: 474.
16. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986.
17. Broyer M, Brunner FP, Brynger H, et al. Kidney transplantation in primary oxalosis: data from the EDTA Registry. Nephrol Dial Transplant 1990; 5: 332.
18. Scheinman JI, Alexander M, Campbell ED, et al. Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 1995; 10 Suppl 8:42-46.
19. Monico CG, Milliner DS. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transplantation 2001; 7: 954.
20. Danpure CJ. Scientific rationale for hepato-renal transplantation in primary hyperoxaluria type 1. In: Touraine JL, ed. Transplantation and Clinical Immunology. Amsterdam: Elsevier, 1991: 91-98.
21. Gagnadoux MF, Lacaille F, Niaudet P, et al. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001; 16: 946.
22. Walden U, Boswald M, Dorr HG, Ruder H. Primary hyperoxaluria 1: catch up growth and normalization of oxaluria 6 years after hepatorenal transplantation in a prepubertal boy. Eur J Pediatr 1999; 158: 727.
23. Wong CS, Gipson DS, Gillen DL, et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 2000; 36: 811.
24. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989; 52: 1-125.
25. Schwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259.
26. Fine RN, Ho M, Tejani A. The contribution of renal transplantation to final adult height: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 2001; 16: 951.
27. Nissel R, Brazda I, Feneberg R, et al. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int 2004; 66: 792.
28. Englund MS, Tyden G, Wikstad I, Berg UB. Growth impairment at renal transplantation - a determinant of growth and final height. Pediatr Transplant 2003; 7: 192.
29. Scheid C, Koul H, Hill WA et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 1996; 49: 413.
30. Koul H, Ebisuno S, Renzulli L, et al. Polarized distribution of oxalate transport systems in LLC-PK1 cells, a line of renal epithelial cells. Am J Physiol 1994; 266: F266.
31. Lash LH, Tokarz JJ. Oxidative stress in isolated rat renal proximal and distal tubular cells. Am J Physiol 1990; 259: F338.
32. Toussaint C, Vienne A, De Pauw L, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Bone histopathology and oxalate body content. Transplantation 1995; 59: 1700.
33. Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998; 11 Suppl 1: 36-41.
34. Broyer M, Guest G, Gagnadoux MF. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr 1992; 120: 721.
35. McDiarmid SV, Gornbein JA, DeSilva PJ, et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999; 67: 404.
36. Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1999; 13: 404.